Notice2021-19224
World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC)
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 7, 2021
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following virtual meeting for the World Trade Center Health Program Scientific/Technical Advisory Committee (WTCHP STAC). A notice of this WTCHP STAC meeting has also been posted on the committee website at: https://www.cdc.gov/wtc/stac_meeting.html.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 170 (Tuesday, September 7, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 170 (Tuesday, September 7, 2021)]
[Notices]
[Pages 50128-50129]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-19224]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2021-0094; NIOSH 248-H]
World Trade Center Health Program Scientific/Technical Advisory
Committee (WTCHP STAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following virtual meeting for the World Trade Center
Health Program Scientific/Technical Advisory Committee (WTCHP STAC). A
notice of this WTCHP STAC meeting has also been posted on the committee
website at: <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>.
DATES: The meeting will be held on September 28, 2021 from 11:00 a.m.
to 4:00 p.m., EDT, and on September 29, 2021 from 11:00 a.m. to 4:00
p.m., EDT.
Written comments received by September 21, 2021 will be provided to
the STAC prior to the meeting.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2021-
0094; NIOSH 248-H by mail. CDC does not accept comments by email.
<bullet> Federal eRulemaking Portal: <a href="https://www.regulations.gov">https://www.regulations.gov</a>.
Follow the instructions for submitting comments.
<bullet> Mail: Docket number CDC-2021-0094; NIOSH 248-H, c/o Sherri
Diana, NIOSH Docket Office, National Institute for Occupational Safety
and Health, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226.
Instructions: All submissions received must include the Agency name
and Docket Number. Written public comments received by September 21,
2021, will be provided to the WTCHP STAC prior to the meeting. Docket
number CDC-2021-0094; NIOSH 248-H will close September 29, 2021.
FOR FURTHER INFORMATION CONTACT: Tania Carre[oacute]n-Valencia, Ph.D.,
Designated Federal Officer, World Trade Center Health Program, National
Institute for Occupational Safety and Health, CDC, 1600 Clifton Road,
NE, MS R-12, Atlanta, GA 30329-4027, Telephone: (513) 841-4515; Email:
<a href="/cdn-cgi/l/email-protection#176063743a646376745774737439707861"><span class="__cf_email__" data-cfemail="0d7a796e207e796c6e4d6e696e236a627b">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The WTCHP STAC was established by Title I of the James
Zadroga 9/11 Health and Compensation Act of 2010, Public Law 111-347
(January 2, 2011), amended by Public Law 114-113 (Dec. 18, 2015) and
Public Law 116-59 (Sept. 27, 2019), adding Title XXXIII to the Public
Health Service (PHS) Act (codified at 42 U.S.C. 300mm to 300mm-61).
Purpose: The purpose of the WTCHP STAC is to review scientific and
medical evidence and to make recommendations to the Administrator of
the World Trade Center (WTC) Health Program regarding additional WTC
Health Program eligibility criteria, potential additions to the List of
WTC-Related Health Conditions, and research regarding certain health
conditions related to the September 11, 2001, terrorist attacks.
Title XXXIII of the PHS Act established the WTC Health Program
within the Department of Health and Human Services (HHS). The WTC
Health Program provides medical monitoring and treatment benefits to
eligible firefighters and related personnel, law enforcement officers,
and rescue, recovery, and cleanup workers who responded to the
September 11, 2001, terrorist attacks in New York City, at the
Pentagon, and in Shanksville, Pennsylvania (responders), and to
eligible persons who were present in the dust or dust cloud on
September 11, 2001 or who worked, resided, or attended school,
childcare, or adult daycare in the New York City disaster area
(survivors). Certain specific activities of the Administrator of the
WTC Health Program are reserved to the Secretary, HHS, to delegate at
his discretion; other duties not explicitly reserved to the Secretary,
HHS, are assigned to the Director of the National Institute for
Occupational Safety and Health (NIOSH). The administration of the WTCHP
STAC is left to the Director of NIOSH in his role as Administrator. CDC
and NIOSH provide funding, staffing, and administrative support
services for the WTCHP STAC. The charter was reissued on May 12, 2021
and will expire on May 12, 2023.
Matters to be Considered: The agenda will include an overview of
the Program's research activities in the past 10 years and discussion
of the Administrator's request that the STAC provide a recommendation
regarding whether to add uterine cancer to the List of health
conditions eligible for coverage by the WTC Health Program. A white
paper on scientific considerations developed to assist the Committee in
their deliberations is available on the WTC Health Program website at
<a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>. An agenda is also posted on
the WTC Health Program website at <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>.
Agenda items are subject to change as priorities dictate. Meeting
Information: This is a virtual meeting conducted via Zoom. The public
is welcome to follow the proceedings via live webcast on the World Wide
Web. No registration is required. The webcast link for September 28-29,
2021 is <a href="https://www.ustream.tv/channel/QyXBRzYjVCS">https://www.ustream.tv/channel/QyXBRzYjVCS</a>. For additional
information please visit the WTC Health Program website at <a href="https://www.cdc.gov/wtc/stac_meeting.html">https://www.cdc.gov/wtc/stac_meeting.html</a>.
Public Participation
Interested parties may participate in this activity by submitting
written views, opinions, recommendations, and
[[Page 50129]]
data. You may submit comments on any topic related to this activity.
Comments received, including attachments and other supporting
materials, are part of the public record and subject to public
disclosure. Do not include any information in your comment or
supporting materials that you consider confidential or inappropriate
for public disclosure. If you include your name, contact information,
or other information that identifies you in the body of your comments,
that information will be on public display. CDC will review all
submissions and may choose to redact, or withhold, submissions
containing private or proprietary information such as Social Security
numbers, medical information, inappropriate language, or duplicate/near
duplicate examples of a mass-mail campaign. CDC will carefully consider
all comments submitted into the docket. CDC does not accept comment by
email.
Oral Public Comment: The public is welcome to participate, via
Zoom, during the public comment periods on September 28, 2021, from
11:30 a.m. to 12:00 p.m., EDT, and on September 29, 2021, from 12:10
p.m. to 12:40 p.m., EDT. Please note that the public comment periods
end at the times indicated above. Each commenter will be provided up to
five minutes for comment. A limited number of time slots are available
and will be assigned on a first come-first served basis. Members of the
public who wish to address the WTCHP STAC during the oral public
comment sessions must sign up by providing their name and desired date
for commenting to Mia Wallace, Committee Management Specialist, via
email: <a href="/cdn-cgi/l/email-protection#e5a8b2848989848680a5868186cb828a93"><span class="__cf_email__" data-cfemail="ade0faccc1c1cccec8edcec9ce83cac2db">[email protected]</span></a>, or the addresses section provided in this
notice by September 21, 2021.
Written Public Comment: Written comments will also be accepted from
those unable to attend the public session per the instructions provided
in the addresses section above. Written comments received in advance of
the meeting will be included in the official record of the meeting.
Written comments received by September 21, 2021 will be provided to the
STAC prior to the meeting. The docket will close on September 29, 2021.
Policy on Redaction of Committee Meeting Transcripts (Public
Comment): Transcripts will be prepared and posted to <a href="http://www.regulations.gov">http://www.regulations.gov</a> within 60 days after the meeting. If a person
making a comment gives their name, no attempt will be made to redact
that name. NIOSH will take reasonable steps to ensure that individuals
making public comments are aware that their comments (including their
name, if provided) will appear in a transcript of the meeting posted on
a public website. Such reasonable steps include a statement read at the
start of the meeting stating that transcripts will be posted, and names
of speakers will not be redacted. If individuals in making a statement
reveal personal information (e.g., medical information) about
themselves, that information will not usually be redacted. The CDC
Freedom of Information Act coordinator will, however, review such
revelations in accordance with the Freedom of Information Act and, if
deemed appropriate, will redact such information. Disclosures of
information concerning third party medical information will be
redacted.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-19224 Filed 9-3-21; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on September 7, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.